6:04 PM
 | 
Apr 25, 2013
 |  BC Extra  |  Financial News

Biogen regains $2.3B in market cap on 1Q13 earns

Biogen Idec Inc. (NASDAQ:BIIB) regained $2.3 billion in market cap on Thursday after raising its 2013 revenue and EPS guidances and reporting 1Q13 earnings that beat the Street. The biotech had gained $2.8 billion in market cap on Monday based on reported early sales of newly launched oral multiple sclerosis drug

Read the full 243 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >